| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 348,526 | 355,056 | 373,816 | 383,974 | | Cost of Revenue | 205,589 | 220,807 | 232,560 | 241,625 | | | Gross Profit | 142,937 | 134,249 | 141,256 | 142,349 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 89,968 | 84,291 | 88,498 | 86,991 | | Non Recurring |
-
|
-
|
-
| 1,094,091 | | Others | 31,798 | 34,936 | 27,458 | 29,232 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,171 | 15,022 | 25,300 | (1,067,965) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,836 | 4,457 | 450 | (15,371) | | Earnings Before Interest And Taxes | 26,707 | 20,024 | 27,093 | (1,082,725) | | Interest Expense | 15,243 | 15,419 | 18,156 | 8,476 | | Income Before Tax | 11,464 | 4,605 | 8,937 | (1,091,201) | | Income Tax Expense | 2,193 | 1,520 | 4,201 | (17,383) | | Minority Interest | 3,822 | 3,792 | 2,513 | 2,985 | | | | Net Income From Continuing Ops | 13,793 | 7,422 | 8,592 | (1,070,833) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 13,093 | 6,877 | 7,249 | (1,070,833) | | Preferred Stock And Other Adjustments |
-
| 3,792 | 2,513 |
-
| | | Net Income Applicable To Common Shares | $13,093 | $6,877 | $7,249 | ($1,070,833) |
|
0.83% Nasdaq 
0.08 (0.68%) 
Income Statement
